DMYD-B.ST
Diamyd Medical AB (publ) [DMYD-B.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DMYD-B.ST Stock Summary
Top 10 Correlated ETFs
DMYD-B.ST
Top 10 Correlated Stocks
DMYD-B.ST
In the News
DMYD-B.ST Financial details
Company Rating
-
Market Cap
980.8M
Income
-117.17M
Revenue
282K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
26
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-6.17
Forward P/E
-
PEG
-2.91
P/S
1425.32
P/B
4.1
P/C
-
P/FCF
-6.36
Quick Ratio
6.42
Current Ratio
7.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.37
EPS next Y
-
EPS next Q
-
EPS this Y
30.97%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
21.89%
Revenue last 5Y
-19.02%
Revenue Q/Q
-23.53%
EPS Q/Q
-16.22%
-
-
-
-
SMA20
-3.85%
SMA50
-51.19%
SMA100
-38.49%
Inst Own
-
Inst Trans
-
ROA
-55%
ROE
-70%
ROC
-0.65%
Gross Margin
-566%
Oper. Margin
-22126%
Profit Margin
-20616%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
6.41-20.991493
52W High
-53.95%
52W Low
+53.5%
RSI
61.08
Rel Volume
5.31
Avg Volume
240.56K
Volume
1.28M
Perf Week
17.77%
Perf Month
10.83%
Perf Quarter
-29.8%
Perf Half Y
-30.12%
-
-
-
-
Beta
2.075
-
-
Volatility
0.52%, 0.34%
Prev Close
10.96%
Price
9.21
Change
16.58%
Company Profile
- Volume Average 240.56K
- Market Capitalization 980.8M
- Employee 26
- CEO Mr. Ulf Hannelius MBA, Ph.D.
- Headquarters Stockholm,SE
- IPO Date 2013-05-20
-
Website
https://www.diamyd.com 
Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase IIb clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is in phase I/II clinical trial for the treatment of autoimmune and type 2 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was incorporated in 1984 and is based in Stockholm, Sweden.
